Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Gynecology

Symptoms, Biology & Diagnosis of MRKH Type 2

At a Glance

MRKH Type 2 is a congenital condition where a female is born without a uterus and upper vagina, and may also have kidney or spinal differences. The main symptom is a lack of menstruation by age 15. Diagnosis typically involves an MRI, hormone panel, and karyotype testing to confirm a 46,XX profile.

The path to an MRKH Type 2 diagnosis usually begins when a young woman reaches age 15 without starting her period, despite having normal breast development and pubic hair [1][2]. This is called primary amenorrhea [2]. Because everything else about puberty feels “on track,” the discovery that the uterus and upper vagina are absent can be a profound shock to both the patient and her family [3].

The Biological “Why”: Müllerian Duct Development

During early pregnancy, every female embryo has Müllerian ducts, which are the biological “blueprints” that eventually become the fallopian tubes, uterus, and upper part of the vagina [2]. In MRKH, these ducts do not develop correctly—a process called aplasia or agenesis [2][4].

While we don’t yet have a single “cause,” research shows this is a multifactorial condition, meaning it likely results from a combination of genetic and environmental triggers [5][6]. Key genes currently being studied include:

  • HOX and WNT genes: These act like master switches that tell the body where to grow organs [6].
  • GREB1L: Variants in this gene are specifically linked to the kidney differences often seen in MRKH Type 2 [7][8].

Ruling Out Other Conditions

When you first seek help for a missing period, your doctor must perform a differential diagnosis to make sure they aren’t misidentifying MRKH for something else.

The most important condition to rule out is Complete Androgen Insensitivity Syndrome (CAIS) [2]. In CAIS, a person is genetically male (46,XY) but their body does not respond to male hormones, so they develop a female outward appearance [9]. To confirm MRKH, a karyotype test is performed to verify that you have a typical female 46,XX genetic profile [2][9].

The Diagnostic “Gold Standard”: MRI

While an ultrasound is often the first test used, Magnetic Resonance Imaging (MRI) is considered the gold standard for diagnosing MRKH Type 2 [10][11].

  • Superior Visualization: MRI provides much clearer pictures than ultrasound. It allows doctors to see your ovaries and identify any rudimentary uterine buds (underdeveloped uterine tissue) [10][12]. Note: In some cases, these small uterine buds contain functional lining and can cause cyclical pelvic pain when hormones fluctuate. If you experience monthly pelvic pain despite having no period, tell your doctor.
  • Checking for Type 2 Features: For MRKH Type 2, doctors use MRI to look beyond the reproductive tract. They check for renal (kidney) differences like a missing or misplaced kidney and skeletal differences like fused bones in the spine [10][13].

Your Diagnostic Completeness Checklist

To ensure your diagnosis is thorough, check your medical records for the following results:

  1. [ ] Karyotype Test: Confirms a 46,XX genetic profile [2].
  2. [ ] Hormonal Panel: Shows typical female levels of estrogen and FSH (follicle-stimulating hormone), proving the ovaries are working [2].
  3. [ ] Pelvic/Abdominal MRI: Identifies any uterine buds and checks for kidney position [10].
  4. [ ] Renal Screening: Specifically looks for renal agenesis (missing kidney) or pelvic kidney [4].
  5. [ ] Spinal Evaluation: Screens for vertebral differences, particularly in the neck (cervical spine) [13].
  6. [ ] Hearing/Cardiac Screens: Recommended as indicated if a MURCS association is heavily suspected [14][15].

Common questions in this guide

Why is an MRI used to diagnose MRKH Type 2?
An MRI is the gold standard because it provides a highly detailed picture of your pelvic area. It allows doctors to visualize your ovaries, identify any small uterine buds, and check for the kidney or skeletal differences that specifically characterize MRKH Type 2.
Why do doctors perform a karyotype test for MRKH?
A karyotype test confirms that you have a typical female 46,XX genetic profile. This is a crucial step in the diagnostic process to rule out other genetic conditions that can cause similar physical characteristics, such as Complete Androgen Insensitivity Syndrome.
Can someone with MRKH Type 2 have periods or pelvic pain?
Because the uterus and upper vagina do not develop correctly, individuals with MRKH do not experience normal menstrual periods. However, some patients have underdeveloped uterine buds that respond to monthly hormone changes, which can cause cyclical pelvic pain even without a period.
What makes MRKH Type 2 different from Type 1?
While both types involve the absent development of the uterus and upper vagina, MRKH Type 2 also includes differences in other body systems. Doctors will specifically screen for differences in the kidneys, spine, and sometimes hearing or the heart.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Why is it important to confirm a 46,XX karyotype in my case?
  2. 2.What did the MRI specifically show regarding my uterine buds and ovaries?
  3. 3.Have we checked my kidneys and spine to fully evaluate for MURCS association features?
  4. 4.Based on my hormone levels, can you confirm that my ovaries are functioning as they should for my age?
  5. 5.Do you suspect any specific genetic factors like GREB1L are involved based on my Type 2 findings?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    ACOG Committee Opinion No. 728: Müllerian Agenesis: Diagnosis, Management, And Treatment.

    Obstetrics and gynecology 2018; (131(1)):e35-e42 doi:10.1097/AOG.0000000000002458.

    PMID: 29266078
  2. 2

    A rare case of 46,XX gonadal dysgenesis, Mayer-Rokitansky-Kuster-Hauser syndrome, pituitary and thyroid hypoplasia.

    Ambachew R, Gulilat A, Aberra T, et al.

    Endocrinology, diabetes & metabolism case reports 2022; (2022()).

    PMID: 35142292
  3. 3

    "I felt like a woman": A phenomenological qualitative study of disease-related experiences in Mayer-Rokitansky-Küster-Hauser syndrome (MRKH syndrome).

    Güner P, Ulukaya T, Pehlivan Sarıbudak T

    Journal of health psychology 2025; (30(11)):3137-3152 doi:10.1177/13591053241305941.

    PMID: 40955819
  4. 4

    Mayer-Rokitansky-Küster-Hauser syndrome with inguinal hernia, left renal fusion, and malrotation: a rare case.

    Li C, Yang H, Xiao H, Yan J

    Therapeutic advances in urology 2025; (17()):17562872251398912 doi:10.1177/17562872251398912.

    PMID: 41328177
  5. 5

    Syndrome Mayer-Rokitansky-Küster-Hauser - uterine and vaginal agenesis: current knowledge and therapeutic options.

    Chmel R, Pastor Z, Mužík M, et al.

    Ceska gynekologie 2019; (84(5)):386-392.

    PMID: 31826637
  6. 6

    Mayer-Rokitansky-Küster-Hauser syndrome type II. Case report.

    Calle JJR

    JBRA assisted reproduction 2025; (29(4)):827-833 doi:10.5935/1518-0557.20250057.

    PMID: 41165215
  7. 7

    GREB1L variants in familial and sporadic hereditary urogenital adysplasia and Mayer-Rokitansky-Kuster-Hauser syndrome.

    Jacquinet A, Boujemla B, Fasquelle C, et al.

    Clinical genetics 2020; (98(2)):126-137 doi:10.1111/cge.13769.

    PMID: 32378186
  8. 8

    Clinical Exome Sequencing Identifies a Novel Mutation of the GREB1L Gene in a Chinese Family with Renal Agenesis.

    Wang A, Ji B, Wu F, Zhao X

    Genetic testing and molecular biomarkers 2020; (24(8)):520-526 doi:10.1089/gtmb.2020.0036.

    PMID: 32598191
  9. 9

    Differences in sex development among individuals with a female phenotype and an absent uterus: Diagnostic approach.

    Jibladze A, Asanidze E, Vash-Margita A, Kristesashvili J

    The Journal of international medical research 2026; (54(6)):3000605261457289 doi:10.1177/03000605261457289.

    PMID: 42316958
  10. 10

    Mayer-Rokitansky-Kuster-Hauser Syndrome: From Radiological Diagnosis to Further Challenges-Review and Update.

    Schiau C, Csutak C, Ciurea AI, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(1)) doi:10.3390/diagnostics16010138.

    PMID: 41515635
  11. 11

    Mayer-Rokitansky-Küster-Hauser Syndrome with Situs Inversus Totalis: A Rare Case Report.

    Soekersi H, Hernowo RPA

    The American journal of case reports 2023; (24()):e939011 doi:10.12659/AJCR.939011.

    PMID: 36772791
  12. 12

    Spectrum of MRI Appearance of Mayer-Rokitansky-Kuster-Hauser (MRKH) Syndrome in Primary Amenorrhea Patients.

    Boruah DK, Sanyal S, Gogoi BB, et al.

    Journal of clinical and diagnostic research : JCDR 2017; (11(7)):TC30-TC35 doi:10.7860/JCDR/2017/29016.10317.

    PMID: 28893003
  13. 13

    Mayer-Rokitansky-Kuster-Hauser syndrome.

    Novoa CCT, Leite MTC, Sartori MGF

    Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia 2025; (47()) doi:10.61622/rbgo/2025FPS4.

    PMID: 40406045
  14. 14

    Mayer-Rokitansky-Kuster-Hauser Syndrome: A Unique Case Presentation.

    Nguyen BT, Dengler KL, Saunders RD

    Military medicine 2018; (183(5-6)):e266-e269 doi:10.1093/milmed/usx066.

    PMID: 29415121
  15. 15

    Vertebral defect, anal atresia, cardiac defect, tracheoesophageal fistula/esophageal atresia, renal defect, and limb defect association with Mayer-Rokitansky-Küster-Hauser syndrome in co-occurrence: two case reports and a review of the literature.

    Bjørsum-Meyer T, Herlin M, Qvist N, Petersen MB

    Journal of medical case reports 2016; (10(1)):374 doi:10.1186/s13256-016-1127-9.

    PMID: 28003020

This page provides educational information about MRKH Type 2 symptoms and diagnosis. Always consult a gynecologist or medical geneticist to interpret your specific test results and imaging.

Get notified when new evidence is published on Mayer-Rokitansky-Küster-Hauser syndrome type 2.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.